The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Merzlikina N.N.

Rossiĭskiĭ natsional'nyĭ issledovatel'skiĭ meditsinskiĭ universitet im. N.I. Pirogova, Moskva

Il'chenko L.Iu.

Rossiĭskiĭ natsional'nyĭ issledovatel'skiĭ meditsinskiĭ universitet im. N.I. Pirogova, Moskva

Fedorov I.G.

Rossiĭskiĭ natsional'nyĭ issledovatel'skiĭ meditsinskiĭ universitet im. N.I. Pirogova;
Gorodskaia klinicheskaia bol'nitsa #12, Moskva

Oskanova R.S.

Rossiĭskiĭ natsional'nyĭ issledovatel'skiĭ meditsinskiĭ universitet im. N.I. Pirogova, Moskva

Storozhakov G.I.

Rossiĭskiĭ natsional'nyĭ issledovatel'skiĭ meditsinskiĭ universitet im. N.I. Pirogova, Moskva

Certain mechanisms underlying the development of bacterial complications in the patients presenting with liver cirrhosis

Authors:

Merzlikina N.N., Il'chenko L.Iu., Fedorov I.G., Oskanova R.S., Storozhakov G.I.

More about the authors

Read: 3361 times


To cite this article:

Merzlikina NN, Il'chenko LIu, Fedorov IG, Oskanova RS, Storozhakov GI. Certain mechanisms underlying the development of bacterial complications in the patients presenting with liver cirrhosis. Russian Journal of Evidence-Based Gastroenterology. 2012;(1):46‑50. (In Russ.)

Recommended articles:
Effe­ctiveness of etiotropic therapy in achieving reco­mpensation of cirrhosis. Russian Journal of Evidence-Based Gastroenterology. 2025;(2):68-77

References:

  1. Storozhakov G.I., Merzlikina N.N., Fedorov I.G. i dr. Osobennosti techeniya infektsionnykh oslozhnenii pri tsirroze pecheni. Klin persp gastroenterol gepatol 2009; 5: 10-17.
  2. Germaud P., Caillet S., Caillon J., Allenet M.C. Community-acquired pneumonia caused by Staphylococcus aureus in non-HIV infected adult patients. Rev Pneumon Clin 1999; 2: 83-87.
  3. Borzio M., Salerno F., Piantoni L. Bacterial infection in patients with advance cirrhosis: a multicentre prospective study. Dig Liver Dis 2001; 5: 41-48.
  4. Bernard B., Cadranel J.-F., Valla D. et al. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology 1995; 108 (6): 1828-1834.
  5. Fernandez J., Navasa M., Gomez J. Bacterial infection in cirrhosis: epidemiological changes with invasive procedures and norfloxacin profilaxis. Hepatology 2002; 35 (1): 140-148.
  6. Khaitov R.M., Ignat'eva G.A., Sidorovich I.G. Immunologiya M: Meditsina 2002; 536.
  7. Gulberg V., Deibert P., Ochs A. et al. Prevention of infectious complications after transjugular intrahepatic portosystemic shunt in cirrotic patients with a single dose of seftriaxone. Hepatogastroenterology 1999; 46 (26): 1126-1130.
  8. Akira S., Takeda K. Toll Receptors: a central element in innate immune. Nat Rev Immunol 2004; 4: 499-511.
  9. De Creus A., Abe M., Lau A.H. et al. Low TLR4 expression bylLiver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J Immunol 2005; 174 (4): 2037-2045.
  10. Vasselon T., Detmers P.A. Toll receptors: a central element in innate immune responses. Infect Immun 2002; 3: 1033-1041.
  11. Schwabe R.F., Seki E., Brenner D.A. Toll-like receptor signaling in the liver. Gastroenterology 2006; 2: 1886-1900.
  12. Koval'chuk L.V., Khoreva M.V, Varivoda A.S. i dr. Retseptory vrozhdennogo immuniteta: podkhody k kolichestvennoi i funktsional'noi otsenke TOLL-podobnykh retseptorov cheloveka. Immunologiya 2008; 29 (4): 223-226.
  13. Seki E., Brenner D.A. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008; 48 (1): 322-335.
  14. West A.P., Koblansky A.A., Ghosh S. Recognition and signaling by toll-like receptors. Ann Rev Cell Dev Biol 2006; 6: 409-437.
  15. Inokuchi S., Tsukamoto H., Park E. et al. Toll-Like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Alcohol Clin Exp Res 2011; 35: 1509-1518.
  16. Gao B., Seki E., Brenner D.A. et al. Innate immunity in alcoholic liver disease. Physiol Gastrointest Liver Physiol 2011; 300: 516-525.
  17. Gao B., Jeong W.I., Tian Z. Liver: an organ with predominant innate immunity. Hepatology 2008; 47 (2): 729-736.
  18. Guarner C., Soriano G. Bacterial translocation and its consequences in patients with cirrhosis. Gastroenterol Hepatol 2005; 1: 45-51.
  19. Cirera I., Bauer T.M., Navasa M. et al. Bacteriafl tranclocation of enteric organisms in patients with cirrhosis. J Hepatol 2001; 34 (1): 32-37.
  20. Pande C., Kumar A., Sarin S.K. Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment Pharmacol Ther 2009; 29: 1273-1281.
  21. Lata J., Stiburek O., Kopacova M. Spontaneous bacterial peritonitis: a severe complication of liver cirrhosis. World J Gastroenterol 2009; 15: 5505-5510.
  22. Such J., Frances R., Munoz C. et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negativ nonneutrocytic ascites. Hepatology 2002; 36 (1): 135-141.
  23. Albillos A., de-la-Hera A., Alvarez-mon M. Serum lipopolysaccharide-binding protein prediction of severe bacterial infections in cirrhotic patients with ascites. Lancet 2004; 6: 1608-1610.
  24. Savel'ev V.S., Gel'fand B.R. Sepsis v nachale XXI veka. M: Litterra 2006; 176.
  25. Kozlov V.K. Sepsis: etiologiya, immunopatogenez, kontseptsiya sovremennoi immunoterapii. SPb: Dialekt 2006; 304

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.